Respiratory Drug Discovery & Development
Argenta Discovery is a respiratory-focused pharmaceutical R&D company. Argenta is developing a pipeline of novel therapies to treat serious diseases such as chronic obstructive pulmonary disease (COPD), severe steroid-insensitive asthma, allergic asthma and cystic fibrosis (CF) with the aim of delivering both improved symptomatic relief and treating the underlying inflammatory disease process. Argenta intends to progress its programmes through Phase IIa proof of concept clinical trials before partnering.
Contract Research
Argenta Discovery also has a successful contract research business offering
integrated drug discovery services to pharmaceutical and
biotech clients.
People
Argenta Discovery is led by a senior
management team with an unparalleled track record of
success in pharmaceutical R&D. Argenta Discovery employs 160 staff and is
based in the UK.
|
 We are developing innovative therapies for COPD, asthma and CF. |
|
Welcome
to Argenta Discovery
